Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women the WHILA study

Maturitas

Volumn 78, Issue 4, 2014, Pages 310-315

  Moberg, Louise M E ^a   Nilsson, Peter M ^a   Samsioe, Göran ^a   Borgfeldt, Christer ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mineral density (BMD); Fracture risk; Postmenopausal women; Previous fracture; Proton pump inhibitors (PPI)

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; LITHIUM; PARACETAMOL; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BONE DENSITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILY HISTORY; FEMALE; FOLLOW UP; FRACTURE; FRAGILITY FRACTURE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; KOLMOGOROV SMIRNOV TEST; MAJOR CLINICAL STUDY; MARRIAGE; PHYSICAL EXAMINATION; POSTMENOPAUSE; PROPHYLAXIS; QUALITY CONTROL; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; SMOKING HABIT; WAIST HIP RATIO; WEIGHT REDUCTION; COMPLICATION; DIABETES MELLITUS; ESTROGEN THERAPY; MIDDLE AGED; OSTEOPOROTIC FRACTURES; POSTMENOPAUSE OSTEOPOROSIS; PROTECTION; REGISTER; RISK; STATISTICAL MODEL;

BONE DENSITY; DIABETES MELLITUS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, BONE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; POSTMENOPAUSE; PROTECTIVE FACTORS; PROTON PUMP INHIBITORS; QUESTIONNAIRES; REGISTRIES; RISK FACTORS;

EID: 84904735229     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.05.019     Document Type: Article

References (21)

1. A. Svedbom, E. Hernlund, M. Ivergard, J. Compston, C. Cooper, and J. Stenmark et al. Osteoporosis in the European Union: a compendium of country-specific reports Arch Osteoporos 8 1-2 2013 137
2. J.A. Kanis, N. Burlet, C. Cooper, P.D. Delmas, J.Y. Reginster, and F. Borgstrom et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 4 2008 399 428
3. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis Report of a WHO Study Group World Health Organ Tech Rep Ser vol. 843 1994 1 129
4. W.D. Leslie, and S. Morin Fracture burden in relation to low bone mineral density and FRAX((R)) probability J Clin Densitom 14 3 2011 279 285
5. J.A. Kanis Diagnosis of osteoporosis and assessment of fracture risk Lancet 359 9321 2002 1929 1936
6. L.A. Fraser, L.E. Targownik, A. Papaioannou, and J.D. Adachi The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study Osteoporos Int 24 4 2013 1161 1168
7. V. Rabenda, V. Rabenda, D. Nicolet, C. Beaudart, O. Bruyere, and J.Y. Reginster Relationship between use of antidepressants and risk of fractures: a meta-analysis Osteoporos Int 24 1 2013 121 137
8. G. Samsioe, G. Samsioe, J. Lidfeldt, C. Nerbrand, and P. Nilsson The women's health in the Lund area (WHILA) study - an overview Maturitas 65 1 2010 37 45
9. C.S. Kwok, J.K. Yeong, and Y.K. Loke Meta-analysis: risk of fractures with acid-suppressing medication Bone 48 4 2011 768 776
10. S. Ngamruengphong, G.I. Leontiadis, S. Radhi, A. Dentino, and K. Nugent Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies Am J Gastroenterol 106 7 2011 1209 1218 quiz 1219
11. L.E. Targownik, W.D. Leslie, K.S. Davison, D. Goltzman, S.A. Jamal, and N. Kreiger et al. The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos) Am J Gastroenterol 107 9 2012 1361 1369
12. K. Ozdil, R. Kahraman, A. Sahin, T. Calhan, E.H. Gozden, and U. Akyuz et al. Bone density in proton pump inhibitors users: a prospective study Rheumatol Int 33 9 2013 2255 2260
13. M.R. Fournier, L.E. Targownik, and W.D. Leslie Proton pump inhibitors: osteoporosis, and osteoporosis-related fractures Maturitas 64 1 2009 9 13
14. M. Salai, D. Somjen, R. Gigi, O. Yakobson, S. Katzburg, and O. Dolkart et al. Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: an in vitro study Bone Joint J 95-B 11 2013 1575 1580
15. J.A. Kanis, O. Johnell, C. De Laet, H. Johansson, A. Oden, and P. Delmas et al. A meta-analysis of previous fracture and subsequent fracture risk Bone 35 2 2004 375 382
16. J. Åstrand, J. Nilsson, and K.G. Thorngren Screening for osteoporosis reduced new fracture incidence by almost half: a 6-year follow-up of 592 fracture patients from an osteoporosis screening program Acta Orthop 83 6 2012 661 665
17. W.D. Leslie, M.R. Rubin, A.V. Schwartz, and J.A. Kanis Type 2 diabetes and bone J Bone Miner Res 27 11 2012 2231 2237
18. A.H. Holmberg, P.M. Nilsson, J.A. Nilsson, and K. Akesson et al. The association between hyperglycemia and fracture risk in middle age. A prospective: population-based study of 22,444 men and 10,902 women J Clin Endocrinol Metab 93 3 2008 815 822
19. F. Xu, Y.P. Ye, Y.H. Dong, F.J. Guo, A.M. Chen, and S.L. Huang Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro J Huazhong Univ Sci Technol Med Sci 33 2 2013 244 249
20. A. Montagnani, and S. Gonnelli Antidiabetic therapy effects on bone metabolism and fracture risk Diabetes Obes Metab 15 9 2013 784 791
21. H. Close, J.M. Mason, D. Wilson, and A.P. Hungin Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study BMC Gastroenterol 12 2012 56